Key facts
- Skin Analytics’s last known valuation is $68.5M (Apr 2025).
- It has raised $42.9M; the latest was Accelerator/Incubator in Sep 2025.
- Notable investors include Innovate UK, Tech Nation Group, UK Research and Innovation, Hoxton Ventures, Bethnal Green Ventures — 31 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 31 names
- ·Watchlist + deal alerts for Skin Analytics
- ·The full record, as it builds
Funding rounds
No funding rounds for Skin Analytics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Skin Analytics
Developer of a skin cancer screening technology designed to help in the early detection of cancer. The company uses artificial intelligence and algorithms to monitor changes in moles and skin lesions and identify skin cancers and precancerous lesions, enabling healthcare providers, particularly within the NHS, to improve patient management efficiency and reduce wait times for skin cancer diagnosis.
- Sector
- Healthcare
- HQ
- Cambridge, United Kingdom
- Founded
- 2012
- Employees
- 94
- Website
- skin-analytics.com/
- Ownership
- Privately Held (backing)
Skin Analytics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Skin Analytics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Skin Analytics in its N-PORT filings yet. We sweep new filings monthly.